Skip to main content
. 2022 Jan 18;10(1):E19–E26. doi: 10.9778/cmajo.20200268

Table 1:

Characteristics of intravenous provision of medical assistance in dying in Ontario between 2016 and 2018 (n = 2895), and in 3 Canadian academic hospitals (in Hamilton and Ottawa, Ontario, and Vancouver, British Columbia) between 2019 and 2020 (n = 662)

Characteristic No. (%) of patients*
n = 3557
Patient age, mean ± SD, yr 74 ± 13.0
Patient sex
 Male 1786 (50.2)
 Female 1770 (49.8)
 Missing 1 (0.03)
Location of MAiD provision (n = 3113)
 Hospital 1382 (44.4)
 Hospice or palliative care facility 187 (6.0)
 Community/other (e.g., private residence, long-term care) 1537 (49.4)
 Missing 7 (0.2)
Patient diagnosis
 Cancer 2519 (70.8)
 Neurologic disorder 23 (0.6)
 Cardiovascular/respiratory disorder 840 (23.6)
 Other 126 (3.5)
 Missing 49 (1.4)
Provider profession
 Physician 3304 (92.9)
 Nurse practitioner 240 (6.7)
 Missing 13 (0.4)
Physician specialty (n = 3113)
 Anesthesia 473 (15.2)
 Critical care 95 (3.0)
 Emergency medicine 96 (3.1)
 Family medicine 1391 (44.7)
 Internal medicine 290 (9.3)
 Neurology 12 (0.4)
 Oncology 1 (0.03)
 Palliative care 382 (12.3)
 Radiation oncology 31 (1.0)
 Surgery 47 (1.5)
 Other 10 (0.3)
 Missing 285 (9.2)

Note: MAiD = medical assistance in dying, SD = standard deviation.

*

Except where noted otherwise.

For Ontario patients only.